Dog Heartworm Disease: Welfare Through Prevention and Treatment

Heartworm disease causes significant welfare suffering in affected dogs, and effective monthly prevention makes it one of the most avoidable serious canine welfare conditions.

Key Facts

Heartworm (Dirofilaria immitis) is transmitted by mosquitoes and endemic across North America, southern Europe, and tropical regions globally
Untreated heartworm causes progressive cardiopulmonary disease, exercise intolerance, and heart failure over 1-3 years
Monthly macrocyclic lactone preventives (ivermectin, milbemycin) are near 100% effective when given consistently
Treatment of established infection with melarsomine requires 60-day exercise restriction — a significant welfare constraint
Post-caval syndrome — when adult worms obstruct the tricuspid valve — has a mortality rate above 50% without emergency surgery

Welfare Considerations

Heartworm disease welfare management is dominated by the prevention versus treatment calculus. Prevention is inexpensive, safe, and essentially 100% effective — treatment is expensive, moderately risky, and requires prolonged exercise restriction that is itself a welfare burden. The welfare case for universal prevention in endemic areas is overwhelming. Access to preventives for low-income dog owners is a welfare equity issue — low-cost veterinary clinics and prescription access programs significantly improve population-level welfare outcomes.

What You Can Do

Administer monthly heartworm prevention year-round if you live in or visit endemic areas
Annual heartworm testing enables early detection before clinical disease develops
Support low-cost veterinary clinic programs that provide heartworm prevention to underserved communities